Title |
Reducing depression during the menopausal transition: study protocol for a randomised controlled trial
|
---|---|
Published in |
Trials, August 2014
|
DOI | 10.1186/1745-6215-15-312 |
Pubmed ID | |
Authors |
Osvaldo P Almeida, Kylie Marsh, Leon Flicker, Martha Hickey, Andrew Ford, Moira Sim |
Abstract |
The menopausal transition (MT) is a biological inevitability for all ageing women that can be associated with changes in mood, including depressive symptoms. There is tentative evidence that women who develop depression during the MT have greater risk of subsequent depressive episodes, as well as increased health morbidity and mortality. Thus, preventing depression during the MT could enhance both current and the future health and well-being of women. This study aims to test the efficacy of a client-centred health promotion intervention to decrease the 12-month incidence of clinically significant symptoms of depression among women undergoing the MT. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 123 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 21 | 17% |
Researcher | 13 | 11% |
Student > Bachelor | 12 | 10% |
Student > Ph. D. Student | 10 | 8% |
Student > Doctoral Student | 7 | 6% |
Other | 19 | 15% |
Unknown | 41 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 20% |
Psychology | 25 | 20% |
Nursing and Health Professions | 15 | 12% |
Social Sciences | 4 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 6 | 5% |
Unknown | 46 | 37% |